Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: PTSC is out for blood
Confused? Who writes this stuff?
| International Stock Targets: Begins Preliminary Research Synthetic Blood International | |||
| |||
| Dec 11, 2007 (M2 PRESSWIRE via COMTEX) -- International Stock Targets has announced a "Strong Buy" recommendation along with a one-month and six-month price target for our newest "Stock Target". Please note that the following is an investment opinion issued by International Stock Targets. For full details on this equity visit the attached link and we highly recommend that all interested small-cap investors contact phone one of our representatives toll free 1 866 657 3334 to get access to our "small-cap" stock pick of the year. Patriot Scientific had a news release December 10th that caught our attention at International Stock Targets. We have therefore also added Synthetic Blood International (PTSC) to our OTCBB Portfolio, their recent market activity has made them a possible candidate for a full analytical research report, to see a sample of our newest report view this link. |
New Message
Please
login
to post a reply